The Journal of Urology
Volume 174, Issue 2 , Pages 534-538 , August 2005

PROSTATE CANCER IN MEN USING TESTOSTERONE SUPPLEMENTATION

,Accepted 27 November 2004.

References 

  1. Huggins C , Hodges CV . Studies on prostatic cancer 1: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate . Cancer Res . 1941;1:293
  2. Ebling DW , Ruffer J , Whittington R , Vanarsdalen K , Broderick GA , Malkowicz SB , et al.   Development of prostate cancer after pituitary dysfunction: a report of 8 patients . Urology . 1997;49:564
  3. Loughlin KR , Richie JP . Prostate cancer after exogenous testosterone treatment for impotence . J Urol . 1997;157:1845
  4. Curran MJ , Bihrle W . Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate . Urology . 1999;53:423
  5. Morgentaler A , Bruning CO , DeWolf WC . Occult prostate cancer in men with low serum testosterone levels . JAMA . 1996;276:1904
  6. Thompson IM , Pauler DK , Goodman PJ , Tangen CM , Lucia MS , Parnes HL , et al.   Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter . N Engl J Med . 2004;350:2239
  7. Thompson IM , Zeidman EJ , Rodriguez FR . Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate . J Urol . 1990;144:1479
  8. Dobs AS , Meikle AW , Arver S , Sanders SW , Caramelli KE , Mazer NA . Pharmacokinetics, efficacy and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men . J Clin Endocrinol Metab . 1999;84:3469
  9. Rhoden EL , Morgentaler A . Risks of testosterone-replacement therapy and recommendations for monitoring . N Engl J Med . 2004;350:482
  10. Yatani R , Chigusa I , Akazaki K , Stemmermann GN , Welsh RA , Correa P . Geographic pathology of latent prostatic carcinoma . Int J Cancer . 1982;29:611
  11. Thompson IM , Goodman PJ , Tangen CM , Lucia CM , Miller GJ , Ford LG , et al.   The influence of finasteride on the development of prostate cancer . N Engl J Med . 2003;349:215
  12. Bhasin S , Singh AB , Mac RP , Carter B , Lee MI , Cunningham GR . Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan . J Androl . 2003;24:299
  13. Hoffman MA , Dewolf WC , Morgantaler A . Is low serum testosterone a marker for high grade prostate cancer? . J Urol . 2000;163:824
  14. Schatzl G , Madersbacher S , Thurridl T , Waldmuller J , Kramer G , Haitel A , et al.   High-grade prostate cancer is associated with lower serum testosterone levels . Prostate . 2001;47:52
  15. Massengill JC , Sun L , Moul JW , Wu H , McLeod DG , Amling C , et al.   Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy . J Urol . 2003;169:1670
  16. Rhoden EL , Morgentaler A . Results of prostate biopsy in men with low serum testosterone . J Urol . 2003;169(suppl.):119; abstract 461
  17. Epstein JI , Walsh PC , Carmichael M , Brendler CB . Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer . JAMA . 1994;271:368
  18. Bhasin S , Buckwalter JG . Testosterone supplementation in older men: a rational idea whose time has not yet come . J Androl . 2001;22:718
  19. Rossouw JE , Anderson GL , Prentice RL , LaCroix AZ , Kooperberg C , Stefanick ML , et al.   Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial . JAMA . 2002;288:321
  20. Loughlin KR . Testosterone replacement therapy. A rush to judgment? . J Urol . 2004;172:827
  21. Kaufman JM , Graydon RJ . Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men . J Urol . 2004;172:920

PII: S0022-5347(01)68302-2

doi: 10.1097/01.ju.0000165166.36280.60

The Journal of Urology
Volume 174, Issue 2 , Pages 534-538 , August 2005

Article Tools